New crown vaccine | When will the vaccine arrive in Hong Kong? News: Kexing has not yet applied to the Hong Kong government for emergency use

Social News

Author: Tao Jiaxin

2021-01-21 15:48

Last update date: 2021-01-21 15:48

The new crown pneumonia epidemic continues, and many people hope that the epidemic will end after vaccination.

The Hong Kong government originally stated that the new crown vaccine from Kexing Biotechnology in the Mainland is expected to arrive in Hong Kong as soon as possible and will arrive in Hong Kong in January this year.

However, Kexing has been delaying the release of its Phase III clinical test data. According to news, until today (21st), Kexing has not submitted an application for emergency use of the new crown vaccine to the Hong Kong government.

It is understood that Kexing still has not submitted an application for emergency use of the new crown vaccine to the Hong Kong government, nor has it officially announced the complete data and report of the third phase of the clinical study.

Kexing conducted Phase III clinical studies in many countries, including Brazil, but since the rise of Deke last year, the date for the release of relevant data has been continuously delayed. Finally, Brazil announced on January 8 this year that the vaccine has an effective rate of 78%.

However, on January 12, Brazil changed its narrative again. If patients with "very mild" symptoms are included, the new "overall effective rate" figure is 50.38%.

▼ Kexing vaccine needs seven steps from the laboratory to the market▼

+9

+9

+9

New crown pneumonia | British media: Oxford prepares to develop a new vaccine to deal with variant virus strains

All things in the political arena︳Tan Yaozong, 71 years old, shares the injection of Sinopharm's new crown vaccine: the young needles are squeezed to eliminate the pain

New crown pneumonia | One country, two systems research center poll: 4 adults are not inclined to the first round of vaccination

01News

New crown pneumonia vaccine